A strategy of transcatheter aortic valve (TAVI) implantation before percutaneous coronary intervention (PCI) is noninferior at 1-year for adverse events versus PCI before TAVI in patients with severe aortic stenosis (AS) and concomitant coronary artery disease (CAD), according to TAVI PCI study results.